Latest in Beats Analysts Estimates
Sort by
910 items
-
A Mastercard executive addresses this burning investor question
Some investors worry it’s going to get harder for Mastercard to find more cash to displace. Its CFO sees plenty of runway ahead.Business - MarketWatch - October 31 -
Analysts tout an 'underappreciated growth driver' at Microsoft that can benefit from AI
RBC analysts cheered Microsoft stock on Tuesday. But, this time it's for more than just the company's cloud computing business and AI ambitions.Business - CNBC - November 5 -
Inside NFL’s boot camp helping players become TV analysts
The NFL’s broadcasting bootcamp is helping prepare its players for post-game careers in broadcast and ensuring that they have successful futures off the field. Players like Devin McCourty, Richard ...Top stories - NBC News - November 7 -
JPMorgan may be ‘best in class’ but it’s time to take profits, analyst says
Baird’s David A. George downgrades megabank to underperform because it’s “more than fully priced” at recent levels.Business - MarketWatch - November 7 -
Football analyst Kirk Herbstreit announces death of beloved dog Ben
Ben Herbstreit was something of a "College GameDay" celebrity, known for accompanying Kirk Herbstreit to college football and NFL games.Sports - Yahoo Sports - November 7 -
Greggs shares fall as analysts predict near-£100mn Budget hit
Low-cost bakery chain has not yet commented on impact but retailers warn that measures will hurtBusiness - Financial Times - November 8 -
Upstart’s stock roars higher. Here’s why analysts say the tide is turning.
Analysts say the AI lender is on a better track is it benefits from an improved interest-rate climate, funding partnerships and “solid” credit trends.Business - MarketWatch - November 8 -
Top Wall Street analysts like these dividend-paying stocks
TipRanks' analyst ranking service pinpoints Wall Street's best-performing stocks, including IBM and Ares Capital.Business - CNBC - November 10 -
Rallying bank stocks have further room to run, analyst says
Hovde’s Feddie Strickland sees additional gains despite rally ‘if history serves as a guide.Business - MarketWatch - November 11 -
Banks may face uncertainties after election euphoria fades: analyst
Moody’s banking strategist Chris Stanley sees potential headwinds along with positive trends for banks in a new Trump administration.Business - MarketWatch - November 11 -
Tesla is likely to thrive in a Trump administration. These are the ways these analysts see it happening.
Analysts at Deutsche Bank set out to explain how exactly they see Tesla benefiting from a Trump administration, given the close association of Chief Executive Elon Musk and Trump, Vice ...Business - MarketWatch - November 12 -
House governance will be ‘very difficult’ for Republicans due to slim majority: analyst
Republicans appear on track to maintain their control of the U.S. House of Representatives in the new year, though yet again a narrow majority looks likely to cause headaches for GOP leaders.Business - MarketWatch - November 12 -
Cava is riding a strong wave, but the stock’s quadrupling in 2024 has analysts wary
Cava Group Inc., the Mediterranean-focused fast-casual restaurant chain, is riding a strong wave that shows no sign of cresting with its latest earnings beating Wall Street estimates on every ...Business - MarketWatch - November 13 -
Analysts are conflicted on industrials — and why we disagree with a sell call on Starbucks
The Investing Club holds its "Morning Meeting" every weekday at 10:20 a.m. ET.Business - CNBC - November 13 -
Top Wall Street analysts are upbeat on these stocks for the long haul
TipRanks' analyst ranking service pinpoints Wall Street's best-performing stocks, including Amazon and Uber Technologies.Business - CNBC - November 17 -
Robinhood poised as ‘major beneficiary’ of Trump’s crypto trading changes: analyst
A boost is expected from crypto-assets listings, as one analyst flags expected changes to securities laws under a Trump administration.Business - MarketWatch - November 18 -
Analysts don’t budge on Williams-Sonoma ratings despite stock rally
After the retailer’s stock hits an all-time high, analysts remained neutral.Business - MarketWatch - 6 days ago -
Why one technical analyst sees a ‘tactical opportunity’ in Treasurys
During recent conversations with MarketWatch, several institutional investors expressed trepidation about buying more Treasury notes and bonds for their portfolios.Business - MarketWatch - 5 days ago -
The Trump effect is 30% priced in, says Deutsche Bank analyst — here’s why
One of the big questions confronting markets is just how much of the impact of a Donald Trump presidency has been priced even before it starts.Business - MarketWatch - 5 days ago -
Gap is still in the early innings of its brand overhaul, but analysts say it’s working
Gap Inc. is still in the early innings of a brand overhaul under Chief Executive Richard Dickson, but the early signs suggest his strategy is working, analysts said Friday.Business - MarketWatch - 5 days ago -
Darian Jenkins reflects on NWSL career, joining CBS Sports as analyst
After retiring from professional soccer, Darian Jenkins is bringing her expertise to CBS Sports. She is best known for her time with the Orlando Pride and North Carolina Courage. Jenkins reflects ...Top stories - CBS News - 5 days ago -
Space stock Redwire soared this year and is set for more ‘investor enthusiasm’: analyst
Redwire, which manufactures and supplies space equipment, has seen its shares skyrocket this year.Business - MarketWatch - Yesterday -
Pfizer tops earnings estimates, hikes full-year guidance as Covid products help sales
It is a critical quarterly report for Pfizer, which is grappling with activist pressure from Starboard Value.Business - CNBC - October 29 -
Eli Lilly stock tumbles after drug giant misses estimates and slashes profit guidance
Skyrocketing demand for weight loss and diabetes drugs has forced Eli Lilly and Novo Nordisk, to invest billions to increase manufacturing capacity.Business - CNBC - October 30 -
Biogen tops estimates, raises profit guidance as Alzheimer's drug Leqembi gains traction
Leqembi, along with rare disease and depression treatments, helped offset a year-over-year decline in revenue for the company's multiple sclerosis products.Business - CNBC - October 30 -
10-, 30-year Treasury yields drop again after GDP data opens door to Q4 slowdown
Yields on long-dated Treasurys closed lower on Wednesday after a weaker-than-expected reading on third-quarter U.S. economic growth gave way to the possibility of another slowdown in the final ...Business - MarketWatch - October 30 -
Samsung falls short of expectations as chipmaker fails to reap AI benefits
Third-quarter operating profit far lower than analyst consensus and trails domestic rival SK HynixWorld - Financial Times - October 31 -
Donald Trump and the autocrats' playbook
‘This is a man who should be nowhere near power’World - Financial Times - October 31